Search
Now showing items 1-10 of 11
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access
Preprint
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
| Date Issued:
2021 | Copyright:
open access
Article
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
| Date Issued:
2022 | Copyright:
open access
Article
COVID-19 hospital admissions: Brazil's first and second waves compared
| Date Issued:
2021 | Copyright:
open access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
Platelet proteome reveals features of cell death, antiviral response and viral replication in covid-19
| Date Issued:
2022 | Copyright:
open access
Article
Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil
| Date Issued:
2021 | Copyright:
open access
Article
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Article
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
| Date Issued:
2022 | Copyright:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access